Thor Oz wins Supplier of the Year - again!

The Thor team in Australia was again delighted to have featured in the Dulux Group 2017 Supplier of the Year Awards function.  Dulux is the largest decorative paint producer in Australia and in 2018 will celebrate 100 years of paint production in Australia.

During the Awards Night held in Melbourne recently, Thor Australia's Area Manager for Southern Australia, Ross Conley, accepted the award on behalf of Thor Specialties, for the second year running, as best supplier to Acratex, the textured coating division of Dulux. The company was also a finalist for Supplier of the Year to Dulux Decorative Paints.

Pictured is Ross receiving the award from Peter Tzokas, Dulux Group Procurement Specialist for raw materials.  Thor Australia MD, Mark Jamieson, congratulated all staff at Thor Australia and acknowledged the huge efforts made by all to achieve this accolade. 

Well done Thor Australia!    


Thor Brazil at Abrafati

Thor Brazil once again exhibited at this premium show for the coatings industry which took place in Sao Paulo 3-5 October this year.

The company put particular emphasis this year on the range of wet state and dry film preservatives available in the marketplace and in particular those dry film biocides benefiting from Thor AMME™, a renowned and highly effective technology offering more effective long term performance with reduced human and environmental risk.

Thor's Dave Alexander, the Group's Technical Marketing expert, presented a paper entitled 'Changing World of Dry Film Preservation' highlighting the regulatory challenges faced by biocide suppliers and coatings manufacturers alike and the benefits that AMME™ technology can bring.  We were delighted to see so many of you at the presentation and at the show and look forward to seeing you again soon!


Thor submits its BPR dossier for Union Authorisation of the C(M)IT/MIT Biocidal Product Family

In the first week of June Thor submitted a BPR1 dossier for Union Authorisation of the C(M)IT/MIT2 Biocidal Product Family including more than 20 ACTICIDE® products.

Following the publication of the Commission Implementing Regulation (EU) 2016/131 of 1 February 2016 approving C(M)IT/MIT as an existing active substance for use in biocidal products, Thor has submitted its dossier for the C(M)IT/MIT Biocidal Product Family. This submission was made approximately one month ahead of the deadline date of 1 July 2017. Thor has supported a Union Authorisation for the C(M)IT/MIT Biocidal Product Family including the product types 2, 4, 6, 11, 12 and 13, covering more than 25 applications.

The BPR concerns the placing on the market as well as the use of biocidal products. Under the BPR, (which replaced the BPD3 on 1 September 2013), all biocidal active substances contained in biocidal products are subject to an application-related evaluation which started with the establishment of the Review Programme in 2000 with a forecasted completion date in 2024. Following the approval of an individual active substance, all biocidal products containing this individual substance need to be authorised.

Thor has conducted studies and applied in use scenarios for each biocidal formulation and the summary of product characteristics (SPCs) was developed to ensure that the stringent risk assessments of the BPR are met for multiple applications, such as the preservation of paints and coatings, slimicide action in paper mills and microbial control in cooling and heating systems.

With the submission of the dossier, the Product Authorisations of Thor customers were initiated either as a marketing company or for Same Biocidal Product Authorisation. Thor’s partners were able to rely on Thor’s expertise during the whole process and thus were able to save both time and money.

To learn more about the measures Thor takes to support customers with Product Authorisations under the BPR, please contact us by email: or talk to one of our sales representatives. 

1 BPR - Biocidal Products Regulation (EU) 528/2012 (BPR)

2 Reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6) (3:1) (Mixture of C(M)IT/MIT)

3 BPD - Biocidal Products Directive (98/8/EC)


Thor China Technical Seminars

Making CosmeticsThor China, along with its distributors, Raysonchem, Heng’an and Banglian Chemical Company, has recently held a series of highly successful technical seminars in Shanghai, Guangzhou and Fujiang.  Over 600 technical engineers or managers represented our customers at the events – pictured are some of the more than 300 participants at the Guangzhou seminar.  

In Shanghai and Guangzhou we introduced our personal care technical service facilities, including microbiological, analytical and formulation testing capabilities, specialist applications laboratory and training centre. New  preservative products Microcare® OCL10, Microcare® GHDI, alkyl silicone wax, special silicone gum and green ecological quat products were discussed with constructive solutions presented to formulators offering new and innovative preservative solutions.  

 In Fujian basic microbiology and the historical development of biocides was highlighted along with guidelines for customers in selecting biocides for a range of applications or to comply with specific regulations such as Ecolabel.

 Feedback from customers was very positive. The seminars served to enhance our strong relationship and technical communication with our customers while also supporting the promotion of Thor products and technical solutions.


CITE Japan 2017

Making CosmeticsThor Japan recently exhibited at this very busy and successful Cosmetics Ingredients & Technology Exhibition which took place in Yokohama 31 May – 2 June.

Several hundred visitors to the Thor stand showed great interest in our preservatives, especially parabens alternatives and non-listed products. However, a particular attraction was a Sensory Bar where customers were able to view and sample our expanding range of unique and attractive silicone products demonstrated by Thor staff.  As ever, Thor’s extensive customer service facilities proved of interest to many.

Thor Japan was delighted with customer response at the show and looks forward to meeting up with all present and future customers at CITE 2019!


Thor busy at the ECS!

Making Cosmetics

It was a busy three days for Thor at this years European Coatings Show, the major biannual show for the paint and coatings industry which took place in Nuremberg 4 - 6 April.

Substantial interest was shown in ACTICIDE® C1 / SCT technology, an innovative MIT free system complying with potential restrictions on MIT in the future. In addition, numerous other MIT free products were discussed with existing and potential customers from around the globe.

Thor representatives from the Performance Chemicals division were also on hand to discuss new developments in flame retardants for coatings and other applications.


ManCare at In-Cosmetics Global

Making Cosmetics
Thor once again exhibited at this prime exhibition for the personal care industry held this year at the ExCel in London over 4-6 April
This year the focus of Thor’s exhibit was on an all new grooming range developed specifically for men! With male grooming products becoming an ever expanding area of the personal care market, Thor demonstrated six innovative new formulations for the face, hair and beard - all incorporating Microcare® Silicones and Microcare® Green Quats.  Over 200 visitors attended the Thor stand to see the formulation demonstrated in our themed 'barbershop' area.

It was wonderful to welcome so many present and future customers to the show and we look forward to seeing you all again next year in Amsterdam. 


Thor Oz supports local hospital

Thor Australia was once again delighted to show its support of the local community hospital close to its Sydney office.  A recent donation has enabled Fairfield Hospital to purchase an additional cardiac monitor.

A spokeswoman for the emergency department explained the value of the machines: "They are an invaluable tool. The machine talks to you and tells you when to defibrillate and whether your CPR compressions are deep enough. It's great that we have access to another monitor!"

Pictured is Thor Australia's MD and Regional Director Mark Jamieson with Office Manager Julie Martin handing over the equipment to Fairfield Hospital's Munya Gwede.